Product Information
UMB-32 is a bromodomain inhibitor. Bromodomains are protein domains that have been shown to be involved in the transcriptional regulation of genes. They bind to acetylated lysine residues on histones and other proteins, which affects the expression of genes. UMB-32 binds to the bromodomain, preventing it from binding with acetylated lysine residues. This prevents gene expression, which interferes with cellular proliferation and development. UMB-32 has been shown to inhibit cancer cells in vitro and in vivo by interfering with the proliferation of cancer cells. It also inhibits HIV infection, as well as combinatorial effects with antiretroviral therapy drugs such as dasatinib or bromosporine.
Chemical properties
Technical inquiry about: UMB-32
Please use instead the cart to request a quotation or an order